- Home
- BLDE vs SCD Comparison
BLDE vs SCD Comparison
Compare BLDE & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- SCD
- Stock Information
- Founded
- BLDE 2014
- SCD 2003
- Country
- BLDE United States
- SCD United States
- Employees
- BLDE N/A
- SCD N/A
- Industry
- BLDE Aerospace
- SCD Trusts Except Educational Religious and Charitable
- Sector
- BLDE Consumer Discretionary
- SCD Finance
- Exchange
- BLDE Nasdaq
- SCD Nasdaq
- Market Cap
- BLDE 276.7M
- SCD N/A
- IPO Year
- BLDE N/A
- SCD N/A
- Fundamental
- Price
- BLDE $3.95
- SCD $16.71
- Analyst Decision
- BLDE Buy
- SCD
- Analyst Count
- BLDE 1
- SCD 0
- Target Price
- BLDE $6.00
- SCD N/A
- AVG Volume (30 Days)
- BLDE 1.6M
- SCD 62.6K
- Earning Date
- BLDE 11-12-2024
- SCD 01-01-0001
- Dividend Yield
- BLDE N/A
- SCD 9.63%
- EPS Growth
- BLDE N/A
- SCD N/A
- EPS
- BLDE N/A
- SCD N/A
- Revenue
- BLDE $241,814,000.00
- SCD N/A
- Revenue This Year
- BLDE $11.34
- SCD N/A
- Revenue Next Year
- BLDE $5.73
- SCD N/A
- P/E Ratio
- BLDE N/A
- SCD N/A
- Revenue Growth
- BLDE 12.04
- SCD N/A
- 52 Week Low
- BLDE $2.45
- SCD $11.33
- 52 Week High
- BLDE $5.17
- SCD $15.87
- Technical
- Relative Strength Index (RSI)
- BLDE 47.19
- SCD 36.96
- Support Level
- BLDE $3.95
- SCD $17.45
- Resistance Level
- BLDE $4.45
- SCD $17.79
- Average True Range (ATR)
- BLDE 0.37
- SCD 0.37
- MACD
- BLDE -0.08
- SCD -0.14
- Stochastic Oscillator
- BLDE 11.45
- SCD 20.65
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.